Magnetic resonance texture alterations in the caudate nucleus following 18 weeks of clozapine treatment in patients with treatment-resistant schizophrenia. [PDF]
Jo W +8 more
europepmc +1 more source
Defining the Patient Journey and Identifying Digital Health Solutions in Treatment-Resistant Schizophrenia. [PDF]
Grasa E +10 more
europepmc +1 more source
Integrating Bioenergetic Therapy Model with Neuropsychopharmacological Interventions in Long-standing Treatment-resistant Schizophrenia: Case Series and Review of Literature. [PDF]
Khairkar P +5 more
europepmc +1 more source
Clinical dilemma of mood stabilizer augmentation in treatment-resistant schizophrenia with residual phase: A case report of valproate-associated hypoglycemia and cytopenia, and subsequent lithium response. [PDF]
Kasagi Y, Okamoto N, Yoshimura R.
europepmc +1 more source
Are cognitive deficits more severe among people with treatment-resistant schizophrenia than treatment responders? [PDF]
Koloth A +6 more
europepmc +1 more source
Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatment. [PDF]
Sun J +12 more
europepmc +1 more source
Exploring High-Dose Olanzapine for Psychosis in an Adolescent With Treatment-Resistant Schizophrenia. [PDF]
Aggarwal S, Sahu SP, Shah P, Knobles MJ.
europepmc +1 more source
Peripheral biomarkers and the philosophy of precision in treatment-resistant schizophrenia. [PDF]
Jerotic S.
europepmc +1 more source

